检索
AI 对话
AI 辅写
analysis
趋势分析
编组
数据平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

A Phase 1 Study Of Flotetuzumab, A Cd123 X Cd3 Dart (R) Protein, Combined With Mga012, An Anti-Pd-1 Antibody, In Patients With Relapsed Or Refractory Acute Myeloid Leukemia

Andrew H. Wei,Chun Yew Fong, Pau Montesinos,Maria Calbacho,Jordi Sierra Gil,Jaime Perez De Oteyza,Jacob M. Rowe,Ofir Wolach,Yishai Ofran,Yakir Moshe,Jichao Sun,Jan Baughman,Eileen McNulty,Ezio Bonvini,Jon M. Wigginton,Jan K Davidson-Moncada

BLOOD（2019）

引用 12|浏览42
暂无评分
摘要
Background
更多
查看译文
关键词
refractory acute myeloid leukemia,acute myeloid leukemia,flotetuzumab,antibody,cd123
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要